1. Pfizer/BioNTech COVID-19 vaccine is safe for elderly people, says WHO — JNJ plans to have 100 million vaccine doses for the US by spring — Assessing physician practices and expectations in the post-COVID era — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Get out while you can

Discussion in 'Exact Sciences' started by anonymous, Aug 1, 2020 at 9:34 AM.

  1. anonymous

    anonymous Guest


    They didn’t say they knew how to do it or that they have the product. Stock tick stunt my friend.
     
  2. anonymous

    anonymous Guest

    you think those numbers were pulled out of someone's ass? Fuck off with your stock stunt bullshit.
     
  3. anonymous

    anonymous Guest

    Maybe your claim here is that you were better off without Pfizer. Is that it? If that’s the case, then you should be irate at Senior Management for sharing profits in a partnership where you’re worse off now. That’s a terrible business decision.

    See...that doesn’t make any sense, does it? Let’s just agree that you needed Pfizer to get to the next level. Whatever success you had came from a massive market need coupled with a great product and no competition. It had nothing to do with ES being a great sales force or a great company. You have a great product.
     
  4. anonymous

    anonymous Guest


    This has to be your first job at a publicly traded company. They don’t have the product man.
     
  5. anonymous

    anonymous Guest

    This has to be your first attempt to pull your head out of your ass.
     
  6. anonymous

    anonymous Guest

    Great company before Pfizer, will be a great company after Pfizer. Nobody cares about your love for Pfizer. Move along to Pfizers page to blow them over there.
     
  7. anonymous

    anonymous Guest


    Pfizer had lost 2 of its blockbuster products and didn't have anything in the pipeline. They were able to hold off more layoffs by partnering with us. They needed us, we needed them. That's how a partnership works. Pfizer is great at selling from a clinical journal, they suck at the operational pull through. Ask any rep out there, Pfizer leans on PMR's and ISR's to do that side of the job. You can't sell CG only selling from a clinical journal, it takes much more pull through than that. Hell, they had no idea what an HL7 interface was when they first went out into the field. They had no idea how to set up ECL, EMR's, nothing.

    Not sure why you have such a hard time looking past your own nose
     
  8. anonymous

    anonymous Guest

    Hearing reps debate who sells from a “glossy” better is funny. Pfizer has the “muscle” globally and operations to take us to the next level.
     
  9. anonymous

    anonymous Guest

    We need them way more than they need us. I like your argument, though. You count on Pfizer to actually generate clinical demand, and then your role is to follow up and set up the operational framework....just like an ISR did before Pfizer. I think you hit the nail on the head of why we needed Pfizer - we just weren’t good enough to generate adequate demand, but we sure were good at computer work and filling out fax forms! Impressive!

    And, you other point is laughable - of course they didn’t know about the ECL and EMR when they started - we never trained them on that out of fear that they would immediately replace the PMR if we gave them everything.

    Wake up. All we bring is CG and some solid admin work that a kid in college could do. They bring everything else that matters.
     
  10. anonymous

    anonymous Guest

    Exact Sciences has a Hostile Toxic work environment, get out while you can.
    Myriad is a superior company with much better management and much better products
     
  11. anonymous

    anonymous Guest

    E.S PMR's work half days and check the box. Complainers. Pfizer sells.
     
  12. anonymous

    anonymous Guest

     
  13. anonymous

    anonymous Guest

    You'll be back, soon you'll see
    You'll remember you belong to me
    You'll be back, time will tell
    You'll remember that I served you well
     
  14. anonymous

    anonymous Guest

     
  15. anonymous

    anonymous Guest

     
  16. anonymous

    anonymous Guest

     
  17. anonymous

    anonymous Guest

    Well...that didn't work out like you thought it would, did it?
     
  18. anonymous

    anonymous Guest


    It ain’t over yet.
     
  19. anonymous

    anonymous Guest

     
  20. anonymous

    anonymous Guest